Premium
Recombinant equine growth hormone administration: effects on synovial fluid biomarkers and cartilage metabolism in horses
Author(s) -
DART A. J.,
LITTLE C. B.,
HUGHES C. E.,
CHU Q.,
DOWLING B. A.,
HODGSON D. R.,
ROSE R. J.,
JOHNSON K. A.
Publication year - 2003
Publication title -
equine veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.82
H-Index - 87
eISSN - 2042-3306
pISSN - 0425-1644
DOI - 10.2746/042516403776148165
Subject(s) - synovial fluid , cartilage , osteoarthritis , aggrecan , medicine , endocrinology , glycosaminoglycan , proteoglycan , chemistry , pathology , articular cartilage , anatomy , alternative medicine
Summary Reasons for performing study : Recombinant equine growth hormone (reGH) has recently been evaluated for effects on body condition and wound healing. It has the potential to influence articular cartilage via stimulation of IGF‐1. Objectives : To investigate effects of administration on synovial joint metabolism. Methods : Six mature horses were given 20 μg/kg bwt reGH daily for 8 weeks by i.m. injection. Three control horses were injected with sterile water. Serum and synovial fluid samples were collected at 6, 8, 11 and 16 weeks for GH and IGF‐1 assays. Articular cartilage harvested at week 16 was evaluated by Western analysis using monoclonal antibodies BC‐13, BC‐4, 8‐A‐4 and CH‐3. Results : Concentrations of IGF‐1 in serum and synovial fluid were significantly elevated (P < 0.05) at 6 and 8 weeks in the reGH group. Glycosaminoglycan concentrations in synovial fluid were significantly less than controls at these time points, suggesting that reGH may modulate proteoglycan metabolism in articular cartilage. In the reGH group, there were not any alterations in synovial fluid content of 3B3(‐) epitope or aggrecan metabolite, or in aggrecan or link protein catabolites retained within cartilage, that might be expected with development of osteoarthritis. Conclusions : Intramuscular administration of reGH may be a more efficient means of delivery of IGF‐1 to joints for cartilage resurfacing initiatives. Potential relevance : We found no alterations in cartilage metabolism indicative of development of osteoarthritis.